← Eichor
Condition: Thalidomide Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Thalidomide

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Thalidomide for the Symptomatic Large Granular Lymphocytic Leukemia
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06530576Thalidomide Therapy for VEOIBD
Phase N/A · 1 location(s) · Children's Hospital of Fudan University · NCT06382519The Therapeutic Effect of Thalidomide in Syringomyelia
Phase 2 · 1 location(s) · Xuanwu Hospital, Beijing · NCT06268093Efficacy and Safety of Low-Dose Cytarabine Combined With Thalidomide in Adult Patients With Untreated LCH
Phase 2 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT07187193Unraveling the Impact of Thalidomide at Diverse Doses in Transfusion Dependent Beta Thalassemia
Phase 2 · 1 location(s) · National Institute of Blood and Marrow Transplant (NIBMT), P · NCT06490627Linperlisib Combination With Cyclophosphamide, Prednisone, and Thalidomide (CPT) in R/R NHL
Phase 2 · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT07195799The Maintenance Treatment of "ITIVA" in AML Patients
NA · 1 location(s) · Henan Cancer Hospital · NCT06256627Efficacy and Safety of Thalidomide Combined With Glutamine in the Treatment of Radiation Intestinal Injury.
Phase 2 · 1 location(s) · Yongquan Shi · NCT06617182Thalidomide Enhances Clinical Efficacy of Cetuximab Combined With Standard Chemotherapy for Left Colorectal Cancer
Phase 2 · 1 location(s) · Xinqiao Hospital of Chongqing · NCT06279351Evaluating the Clinical Efficacy and Safety of Luspatercept Combined With Thalidomide in the Treatment of β-TDT Patients
Phase 2 · 8 location(s) · Rongrong Liu · NCT07338344Thalidomide to Chemotherapy Related Nausea and Vomiting in Pancreatic Cancer
Phase 3 · 1 location(s) · Fudan University · NCT06017284Metronomic Gemcitabine, Mitomycin C, and Thalidomide for Advanced Solid Tumors
Phase 2 · 1 location(s) · Sarcoma Oncology Research Center, LLC · NCT07671534Two Schemes Response in Multiple Myeloma
Phase N/A · 1 location(s) · Hospital General de Mexico · NCT06284395
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.